Raj Shrivastava, MD
img_Raj Shrivastava
PROFESSOR | Neurosurgery
PROFESSOR | Otolaryngology
Are you a patient?
Research Topics
Anatomy, Anti-Tumor Therapy, Bioinformatics, Brain, Brain Imaging, Clinical Genomics, Computer Simulation, Genomics, MRI, Neural Networks, Neuroscience, Pituitary, Robotic Surgery, Systems Neuroscience, Translational Research
Ultra-High Field MRI Tumor Mapping
The BioMedical Engineering and Imaging Institute (BMEII) research group has an NIH funded program that develops newer techniques to accurately map tumors and anatomy using ultra-high field 7T MRI. This will allow for more precise and targeted surgical resections-ultimately for better patient outcomes.

The BioMedical Engineering and Imaging Institute

Endoscopic Skull Base Surgery
The Endoscopic Skull Base Surgery research group focuses on the clinical implementation of stereotactic and 3D navigation for minimally invasive skull base and pituitary tumor surgery. The team researches unique visual-evoked-potential (VEP) neuro-physiological monitoring to monitor visual pathways during neurosurgical tumor surgery to provide for improved clinical outcome.

Endoscopic Skull Base Surgery

BS, MS, Stanford University

MD, University of Pennsylvania

Internship, Surgery (General Surgery), Mount Sinai Hospital

Residency, Neurosurgery, Mount Sinai Hospital

Fellowship, Neurosurgery, St. Luke's-Roosevelt Hospital Center


American Board of Neurological Surgery

2017, 2019, 2020

New York Magazine Best Doctors


America's Top Surgeon Award


Castle Connolly Top Doctors

Castle Connolly


US News and World Report Selected Top Doctor-Neurosurgery


Patient's Choice Award - National Award


Compassionate Physician Award - National Award

Patient's Choice - Vital Health Care Group


American Association of Neurosurgeons (AANS) Vesalius Award - First Presentation

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Shrivastava did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.